Hexcel
HXL
83.90
-2.11
-2.45%
Hexcel
US · HXL
#1846 by market cap
Listed 1970
83.90
-2.11
-2.45%
Live - 5344 symbols - heartbeat 500s ago
· 2026-10-07 20:02
After-hours
83.90
0.00%
- Market cap
- 6.34B
- P/E (TTM)i
- 42.37
- P/Bi
- 4.89
- EPSi
- 1.37
- Div yieldi
- 0.83%
- 52W posi
- 46%
Reader sentiment
Are you bullish or bearish on HXL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.90, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.48% YoY
Margins
- Gross margin
- 22.96%
- Operating margin
- 9.06%
- Net margin
- 5.78%
Key ratios & quality
- Altman Z-Scorei
- 4.90
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.19B | 2.36B | 1.50B | 1.32B | 1.58B | 1.79B | 1.90B | 1.89B |
| Gross profit | 580.80M | 640.40M | 239.70M | 250.10M | 357.10M | 433.20M | 469.80M | 434.80M |
| Selling & admin expenses | 146.00M | 158.70M | 121.10M | 135.00M | 148.00M | 163.80M | 176.60M | 169.00M |
| Research & development | 55.90M | 56.50M | 46.60M | 45.10M | 45.80M | 52.70M | 57.10M | 56.40M |
| Operating profit | 371.20M | 425.20M | 14.10M | 51.80M | 175.20M | 215.30M | 186.10M | 171.60M |
| Pretax profit | 333.50M | 379.70M | -27.70M | 22.00M | 149.80M | 109.70M | 154.90M | 135.00M |
| Tax | 62.50M | 76.80M | -61.00M | 5.90M | 31.60M | 12.10M | 22.80M | 25.60M |
| Net profit | 276.60M | 306.60M | 31.70M | 16.10M | 126.30M | 105.70M | 132.10M | 109.40M |
| Basic EPS | 3 | 4 | 0 | 0 | 2 | 1 | 2 | 1 |
| Diluted EPS | 3.11 | 3.57 | 0.38 | 0.19 | 1.49 | 1.24 | 1.59 | 1.37 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 456.50M | 489.90M | 456.20M | 491.30M | 501.50M | 529.30M |
| Gross profit | 102.40M | 111.50M | 99.90M | 121.00M | 134.70M | 138.10M |
| Selling & admin expenses | 43.30M | 43.00M | 41.10M | 41.60M | 49.40M | 47.20M |
| Research & development | 13.80M | 14.30M | 14.00M | 14.30M | 17.80M | 17.30M |
| Operating profit | 44.20M | 30.00M | 36.00M | 61.40M | 57.60M | 72.60M |
| Pretax profit | 36.00M | 21.80M | 26.80M | 50.40M | 45.50M | 60.70M |
| Tax | 7.10M | 8.30M | 6.20M | 4.00M | 8.30M | 11.40M |
| Net profit | 28.90M | 13.50M | 20.60M | 46.40M | 37.20M | 49.30M |
| Basic EPS | 0 | 0 | 0 | 1 | 0 | 1 |
| Diluted EPS | 0.35 | 0.17 | 0.26 | 0.60 | 0.49 | 0.64 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 675.80M | 704.90M | 535.90M | 616.30M | 734.40M | 864.20M | 781.50M | 730.70M |
| Cash & ST investments | 32.70M | 64.40M | 103.30M | 127.70M | 112.00M | 227.00M | 125.40M | 71.00M |
| Inventory | 297.80M | 333.10M | 213.50M | 245.70M | 319.30M | 334.40M | 356.20M | 328.80M |
| Total assets | 2.82B | 3.13B | 2.92B | 2.82B | 2.84B | 2.92B | 2.73B | 2.70B |
| Total current liabilities | 326.70M | 322.60M | 183.10M | 247.60M | 329.80M | 315.90M | 353.50M | 322.70M |
| Short-term debt | 9.40M | 9.50M | 900.00K | 900.00K | 200.00K | 100.00K | 100.00K | -- |
| Long-term debt | 946.60M | 1.05B | 923.00M | 820.90M | 721.90M | 697.70M | 698.70M | 990.90M |
| Total liabilities | 1,502,100,000.00 | 1,682,500,000.00 | 1,407,600,000.00 | 1,333,900,000.00 | 1,283,100,000.00 | 1,202,000,000.00 | 1,197,700,000.00 | 1,453,300,000.00 |
| Total equity | 1.32B | 1.45B | 1.51B | 1.49B | 1.55B | 1.72B | 1.53B | 1.25B |
| Retained earnings | 1.73B | 1.98B | 2.00B | 2.01B | 2.10B | 2.17B | 2.25B | 2.31B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 822.50M | 847.40M | 787.40M | 730.70M | 769.70M | 792.20M |
| Cash & ST investments | 89.20M | 77.20M | 90.50M | 71.00M | 54.10M | 62.20M |
| Inventory | 381.50M | 375.40M | 357.60M | 328.80M | 339.80M | 345.20M |
| Total assets | 2.78B | 2.84B | 2.76B | 2.70B | 2.72B | 2.73B |
| Total current liabilities | 317.50M | 315.50M | 286.00M | 322.70M | 313.70M | 326.40M |
| Short-term debt | 100.00K | -- | -- | -- | -- | -- |
| Long-term debt | 785.20M | 825.40M | 755.60M | 990.90M | 996.10M | 957.50M |
| Total liabilities | 1,246,600,000.00 | 1,289,400,000.00 | 1,191,700,000.00 | 1,453,300,000.00 | 1,457,700,000.00 | 1,432,400,000.00 |
| Total equity | 1.53B | 1.55B | 1.57B | 1.25B | 1.27B | 1.30B |
| Retained earnings | 2.27B | 2.27B | 2.27B | 2.31B | 2.33B | 2.37B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 421.40M | 491.10M | 264.30M | 151.70M | 173.10M | 257.10M | 289.90M | 230.50M |
| Depreciation & amortization | 123.10M | 141.70M | 140.90M | 138.00M | 126.20M | 124.80M | 124.00M | 122.30M |
| Free cash flow | 237.30M | 287.00M | 213.70M | 123.80M | 96.80M | 148.90M | 202.90M | 157.20M |
| Dividends paid | -48.40M | -54.20M | -14.20M | 0 | -33.70M | -42.20M | -49.30M | -53.90M |
| Stock buybacks / issuance | -357.70M | -143.00M | -24.60M | 0 | 0 | -30.10M | -252.20M | -454.30M |
| Ending cash balance | 32.70M | 64.40M | 103.30M | 127.70M | 112.00M | 227.00M | 125.40M | 71.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -28.50M | 23.30M | 110.20M | 125.50M | 19.00M | 77.70M |
| Depreciation & amortization | 29.80M | 30.80M | 30.90M | 30.80M | 30.40M | 30.10M |
| Free cash flow | -54.60M | 8.00M | 96.50M | 107.30M | -6.20M | 58.00M |
| Dividends paid | -13.80M | -13.70M | -13.50M | -12.90M | -13.70M | -13.60M |
| Stock buybacks / issuance | -50.40M | -50.50M | 0 | -353.40M | 0 | 0 |
| Ending cash balance | 89.20M | 77.20M | 90.50M | 71.00M | 54.10M | 62.20M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 19.64 | 22.15 | 2.14 | 1.07 | 8.31 | 6.46 | 8.14 | 7.87 |
| ROA %i | 9.87 | 10.30 | 1.05 | 0.56 | 4.47 | 3.67 | 4.68 | 4.03 |
| ROIC %i | 13.40 | 14.33 | 2.52 | 1.86 | 6.75 | 5.79 | 6.83 | 6.26 |
| 5-year avg ROE %i | 19.89 | 20.70 | 17.05 | 13.15 | 10.66 | 8.03 | 5.23 | 6.37 |
| EBIT margin %i | 16.96 | 18.05 | 0.94 | 4.55 | 11.79 | 8.03 | 9.78 | 9.12 |
| FCF / sales %i | 10.84 | 12.18 | 14.22 | 9.35 | 6.14 | 8.32 | 10.66 | 8.30 |
| Current ratioi | 2.07 | 2.19 | 2.93 | 2.49 | 2.23 | 2.74 | 2.21 | 2.26 |
| Quick ratioi | 1.05 | 1.07 | 1.48 | 1.29 | 1.11 | 1.54 | 1.04 | 1.10 |
| Debt / assetsi | 33.88 | 33.88 | 31.75 | 29.20 | 25.50 | 23.97 | 25.71 | 36.72 |
| LT debt / equityi | 71.66 | 72.65 | 61.28 | 55.36 | 46.54 | 40.75 | 45.85 | 79.40 |
| Interest coveragei | 9.85 | 9.35 | 0.34 | 1.57 | 5.14 | 4.23 | 5.96 | 4.58 |
| Revenue CAGR (3Y) %i | 5.56 | 5.53 | -8.69 | -15.42 | -12.51 | 5.99 | 12.83 | 6.28 |
| Net income CAGR (3Y) %i | 5.26 | 7.07 | -51.85 | -61.25 | -25.59 | 49.40 | 101.69 | -4.68 |
| FCF CAGR (3Y) %i | -- | 57.47 | 12.37 | -19.50 | -30.39 | -11.35 | 17.90 | 17.54 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 7.87 | 5.63 | 4.36 | 7.87 | 8.41 | 10.76 |
| ROA %i | 4.45 | 3.10 | 2.45 | 4.03 | 4.28 | 5.51 |
| ROIC %i | 6.54 | 4.92 | 4.08 | 6.26 | 6.62 | 8.23 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 9.38 | 7.25 | 6.37 | 9.12 | 9.60 | 11.53 |
| FCF / sales %i | 9.75 | 9.10 | 10.33 | 8.30 | 10.60 | 12.92 |
| Current ratioi | 2.59 | 2.69 | 2.75 | 2.26 | 2.45 | 2.43 |
| Quick ratioi | 1.21 | 1.23 | 1.27 | 1.10 | 1.23 | 1.23 |
| Debt / assetsi | 28.32 | 29.11 | 27.48 | 36.72 | 36.64 | 35.14 |
| LT debt / equityi | 51.36 | 53.27 | 48.38 | 79.40 | 78.83 | 73.90 |
| Interest coveragei | 5.45 | 4.06 | 3.50 | 4.58 | 4.47 | 5.11 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Composite Materials is the largest reported line at 84.77% of revenue, across 3 reported segments.
- The next-largest line, Engineered Products, is a distant second at 20.65% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Composite Materials84.77%
Engineered Products20.65%
Quote time 2026-10-07 20:02:24 · For reference only, not investment advice and not tailored to your situation.